Effects of low-frequency ultrasound combined with anti-MRSA agents on the mouse model of pulmonary infection

Kaicheng Yan,Jiahui Yao,Lingling Liu,Wenxin Liang,Yun Cai
DOI: https://doi.org/10.1128/spectrum.01016-23
IF: 3.7
2024-02-07
Microbiology Spectrum
Abstract:Treating pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) with antibiotics alone poses significant challenges. In this in vivo study, we present compelling evidence supporting the efficacy of low-frequency ultrasound (LFU) as a promising approach to overcome these obstacles. Our findings demonstrated that LFU enhanced the effectiveness of vancomycin, linezolid, and contezolid in an MRSA pneumonia model. The combination of LFU with anti-MRSA agents markedly improved the survival rate of mice, accelerated the clearance of pulmonary bacteria, reduced inflammatory injury, inhibited the production of MRSA endotoxin, and enhanced the distribution of antibiotics in lung tissue. The application of LFU in the treatment of pulmonary infections held substantial significance. We believe that readers of your journal will find this topic of considerable interest.
microbiology
What problem does this paper attempt to address?